These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2784112

  • 21. The effects of the anaphylatoxins C3a and C5a on isolated mast cells from rat and man.
    Jürgensen H, Behrendt H, Damerau B, Schmutzler W.
    Agents Actions; 1986 Apr; 18(1-2):153-4. PubMed ID: 2425572
    [Abstract] [Full Text] [Related]

  • 22. Anaphylatoxin-induced histamine release with human leukocytes: studies of C3a leukocyte binding and histamine release.
    Glovsky MM, Hugli TE, Ishizaka T, Lichtenstein LM, Erickson BW.
    J Clin Invest; 1979 Sep; 64(3):804-11. PubMed ID: 89118
    [Abstract] [Full Text] [Related]

  • 23. Eicosanoid-mediated increase in glucose and lactate output as well as decrease and redistribution of flow by complement-activated rat serum in perfused rat liver.
    Muschol W, Püschel GP, Hülsmann M, Jungermann K.
    Eur J Biochem; 1991 Mar 14; 196(2):525-30. PubMed ID: 2007411
    [Abstract] [Full Text] [Related]

  • 24. Comparative structural anatomy of the complement anaphylatoxin proteins C3a, C4a and C5a.
    Greer J.
    Enzyme; 1986 Mar 14; 36(1-2):150-63. PubMed ID: 3491754
    [Abstract] [Full Text] [Related]

  • 25. Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxic peptides) by ELISAs with monoclonal antibodies.
    Klos A, Ihrig V, Messner M, Grabbe J, Bitter-Suermann D.
    J Immunol Methods; 1988 Jul 22; 111(2):241-52. PubMed ID: 3260926
    [Abstract] [Full Text] [Related]

  • 26. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M, Bengtson A, Karlsson K, Heideman M.
    Obstet Gynecol; 1989 Apr 22; 73(4):551-6. PubMed ID: 2784554
    [Abstract] [Full Text] [Related]

  • 27. Complement activation requirements for histamine release from human leukocytes: influence of purified C3ahu and C5ahu on histamine release.
    Hartman CT, Glovsky MM.
    Int Arch Allergy Appl Immunol; 1981 Apr 22; 66(3):274-81. PubMed ID: 6170591
    [Abstract] [Full Text] [Related]

  • 28. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation.
    Nagata S, Glovsky MM.
    J Allergy Clin Immunol; 1987 Jul 22; 80(1):24-32. PubMed ID: 3496373
    [Abstract] [Full Text] [Related]

  • 29. Microvascular effects of anaphylatoxins C3a and C5a.
    Björk J, Hugli TE, Smedegård G.
    J Immunol; 1985 Feb 22; 134(2):1115-9. PubMed ID: 3871207
    [Abstract] [Full Text] [Related]

  • 30. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
    Maruo K, Akaike T, Ono T, Okamoto T, Maeda H.
    J Allergy Clin Immunol; 1997 Aug 22; 100(2):253-60. PubMed ID: 9275149
    [Abstract] [Full Text] [Related]

  • 31. Induction of platelet aggregation by the complement-derived peptides C3a and C5a.
    Grossklaus C, Damerau B, Lemgo E, Vogt W.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 22; 295(1):71-6. PubMed ID: 1004644
    [Abstract] [Full Text] [Related]

  • 32. Complement anaphylatoxins in idiopathic mixed cryoglobulinemia.
    Miadonna A, Leggieri E, Tedeschi A, Cottini M, Invernizzi F, Froldi M, Zanussi C.
    Int Arch Allergy Appl Immunol; 1985 Oct 22; 76(2):120-5. PubMed ID: 3967939
    [Abstract] [Full Text] [Related]

  • 33. Endotoxin-induced shock in the rat. A role for C5a.
    Smedegård G, Cui LX, Hugli TE.
    Am J Pathol; 1989 Sep 22; 135(3):489-97. PubMed ID: 2789475
    [Abstract] [Full Text] [Related]

  • 34. Differences in the involvement of prostanoids from Kupffer cells in the mediation of anaphylatoxin C5a-, zymosan-, and lipopolysaccharide-dependent hepatic glucose output and flow reduction.
    Pestel S, Schlaf G, Götze O, Jungermann K, Schieferdecker HL.
    Lab Invest; 2003 Dec 22; 83(12):1733-41. PubMed ID: 14691291
    [Abstract] [Full Text] [Related]

  • 35. Structure and function of the anaphylatoxins.
    Hugli TE.
    Springer Semin Immunopathol; 1984 Dec 22; 7(2-3):193-219. PubMed ID: 6387982
    [Abstract] [Full Text] [Related]

  • 36. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
    Sergeev IuV, Reznikov IuP, Lobanova EV, Pimenova NS.
    Vestn Dermatol Venerol; 1989 Dec 22; (4):4-7. PubMed ID: 2788339
    [Abstract] [Full Text] [Related]

  • 37. Anaphylatoxins inhibit C2 production.
    Lappin D, Damerau B, Whaley K.
    Clin Exp Immunol; 1983 Nov 22; 54(2):455-60. PubMed ID: 6317240
    [Abstract] [Full Text] [Related]

  • 38. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G, Schieferdecker HL, Rothermel E, Jungermann K, Götze O.
    Lab Invest; 1999 Oct 22; 79(10):1287-97. PubMed ID: 10532591
    [Abstract] [Full Text] [Related]

  • 39. Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.
    Hartung HP, Schwenke C, Bitter-Suermann D, Toyka KV.
    Neurology; 1987 Jun 22; 37(6):1006-9. PubMed ID: 3495747
    [Abstract] [Full Text] [Related]

  • 40. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W, Kretzschmar T, Stühmer T, Kola A, Emde M, Köhl J, Klos A, Bitter-Suermann D.
    Biochem J; 1992 Nov 15; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.